Bruce Allan Hay

This inventor holds 27 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Cancer Treatment Formulations. Top assignees: General Electric Company, Nammi Therapeutics, Inc., Nanopharmaceuticals LLC. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruce Allan Hay. Retrieved from https://idiyas.com/inventor/bruce-allan-hay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27 (Patent Applications = 10)

% Patents Active = 92.6

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 18(Granted Patents)

Company Filing History:

13 out of 52,395

General Electric Company

patents

10 out of 11

Nammi Therapeutics, Inc.

patents

3 out of 21

Nanopharmaceuticals LLC

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Liposome Compositions

Cancer Treatment

Nanoparticle Contrast Agents

TLR Agonist Prodrugs

A2aR Antagonist Prodrugs

IDO Antagonist Prodrugs

PD-1 Antagonist Prodrugs

Thyrointegrin Antagonists

Superparamagnetic Nanoparticles

Molecular Imaging Agents

Polypeptide-Aptamer Conjugates

Magnetic Material Imaging

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12702695 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2026-08-11),

2. 12653829 - Formulated and/or co-formulated compositions containing A2aR antagonist prodrugs useful in the treatment of cancer and methods thereof (2026-06-16),

3. 12624109 - αv-integrin targeted small molecule drug conjugates (2026-05-12),

4. 12311010 - Formulated and/or co-formulated liposome compositions containing toll-like receptor('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2025-05-27),

5. 12286403 - Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof (2025-04-29),

6. 12059470 - Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof (2024-08-13),

7. 11896646 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2024-02-13),

8. 11833209 - Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof (2023-12-05),

9. 11801304 - Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof (2023-10-31),

10. 11744874 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2023-09-05),

11. 11723888 - Polymer conjugated thyrointegrin antagonists (2023-08-15),

12. 11679141 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2023-06-20),

13. 11186551 - Composition of scalable thyrointegrin antagonists with improved retention in tumors (2021-11-30),

14. 10961204 - Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors (2021-03-30),

15. 10450345 - Method of isolation of polypeptide-aptamer-polymer conjugates (2019-10-22),

Title: The Inventor Bruce Allan Hay: Pioneering Innovations in Niskayuna

Introduction: Bruce Allan Hay is a distinguished inventor based in Niskayuna, NY, known for his groundbreaking contributions to various technological fields.

Latest Patents: Bruce Allan Hay holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics, showcasing his commitment to driving innovation forward.

Career Highlights: With a career spanning over two decades, Bruce Allan Hay has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Bruce Allan Hay has collaborated with top engineers, scientists, and researchers, fostering a culture of creativity and excellence that has led to numerous successful projects.

Conclusion: Bruce Allan Hay's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.